Edward Gillis - VP of Catheter Development

Ed Gillis joined BioCardia in 2020.  Prior to joining us, Ed served as Chief Technical Officer and as President and Chief Executive Officer of ReVENT Medical, Inc., a company he founded.  Prior to that he served as Vice President of Research and Development for SineXus (now Intersect ENT) and Apneon, an obstructive sleep apnea company.  Ed was VP of Manufacturing and Engineering for Durect Corporation a pharmaceutical company developing drug delivery systems, catheters, and other delivery platforms. Previously, Ed worked in senior positions in manufacturing and product development for EndoTex Interventional Systems and Cardiac Pathways Corporation (both acquired by Boston Scientific) and engineering positions at Spectranetics Corporation, Guidant Corporation and Baxter Healthcare. He has built from scratch and provided leadership for early stage companies as well as R&D and manufacturing organizations.  Ed received his Bachelor of Science in Biology and Master of Science in Plastics Engineering from The University of Massachusetts Lowell. He holds 34 US patents with 100+ issued and pending worldwide and is named author on scientific publications in the areas of obstructive sleep apnea, catheter design and drug delivery.

News


Have questions?
CALL US NOW
: (800) 624-1179
Have questions?
EMAIL US NOW
: info@biocardia.com

biocardia takes a new and comprehensive
approach to heart failure

By introducing patient screening and highly-efficient delivery to stem cell therapy, the company seeks to increase the likelihood of treatment success, enabling more patients to return to the things they love.